UK markets closed

CytoMed Therapeutics Limited (GDTC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.0200-0.1300 (-6.05%)
As of 10:18AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in SGD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
1,590
1,590
1,523
1,091
1,038
Selling general and administrative
1,284
1,284
397.111
291.316
197.01
Total operating expenses
3,843
3,843
1,857
1,728
1,256
Operating income or loss
-3,843
-3,843
-1,857
-1,728
-1,256
Interest expense
51.282
51.282
125.175
117.696
105.519
Total other income/expenses net
-524.108
-524.108
-1,150
-209.393
-573.856
Income before tax
-4,133
-4,133
-3,130
-2,052
-1,936
Income tax expense
0.653
0.653
1.64
0
0
Income from continuing operations
-4,133
-4,133
-3,131
-2,052
-1,936
Net income
-4,133
-4,133
-3,131
-2,052
-1,935
Net income available to common shareholders
-4,133
-4,133
-3,131
-2,052
-1,935
Basic EPS
-0.37
-0.39
-0.29
-0.19
-0.18
Diluted EPS
-0.37
-0.39
-0.29
-0.19
-0.18
Basic average shares
11,529
10,630
10,940
10,940
10,940
Diluted average shares
11,529
10,630
10,940
10,940
10,940